GLSynthesis Inc.


Overview

GLSynthesis Inc. has established a drug discovery service business (custom organic synthesis, analytical chemistry and rodent pharmacology) to provide compounds and services to pharmaceutical and biotechnology companies and research institutions, and to carry out drug and chemical product R&D through corporate contracts and small business grants.

Management Team

CSO

Ivan Borrisov Yanachkov

M.S. (1980) and Ph.D. (1987), University of Chemical Technology and Metallurgy, Sofia, Bulgaria. Ph.D. in Chemistry (1996), Clark University, Worcester, MA. Senior Scientist, Drug Innovation and Design, Waltham, MA. Senior Scientist, GLSynthesis, Worcester, MA. Accomplished nucleoside/tide chemist and analyst. Director of Quality Control at GLSynthesis Inc. He leads antithrombotic drug synthesis and development.

CEO

George Edward Wright

B.S in pharmacy, 1963; Ph.D. in pharmaceutical chemistry, 1967. Professor of Pharmacology, University of Massachusetts Medical School, 1974-96.

George Wright